( 0 1 0 1 O
H/ 1 3 1 3 O
o 4 5 4 5 O
) 5 6 5 6 O
Crohn 7 12 7 12 B-chronic_disease
's 12 14 12 14 I-chronic_disease
disease/ 15 23 15 23 I-chronic_disease
ulcerative 24 34 24 34 B-chronic_disease
colitis/ 35 43 35 43 I-chronic_disease
scleroderma 44 55 44 55 B-chronic_disease

Absolute 0 8 56 64 B-clinical_variable
neutrophil 9 19 65 75 I-clinical_variable
count 20 25 76 81 I-clinical_variable
( 26 27 82 83 I-clinical_variable
ANC 27 30 83 86 I-clinical_variable
) 30 31 86 87 I-clinical_variable
> 32 33 88 89 O
= 33 34 89 90 O
1,500 35 40 91 96 B-lower_bound
cells 41 46 97 102 I-lower_bound
/ 46 47 102 103 I-lower_bound
mm3 47 50 103 106 I-lower_bound

Any 0 3 107 110 O
prior 4 9 111 116 B-treatment
external 10 18 117 125 I-treatment
beam 19 23 126 130 I-treatment
radiation 24 33 131 140 I-treatment
will 34 38 141 145 O
be 39 41 146 148 O
evaluated 42 51 149 158 O
to 52 54 159 161 O
determine 55 64 162 171 O
radiation 65 74 172 181 O
field 75 80 182 187 O
overlaps 81 89 188 196 O
and 90 93 197 200 O
appropriateness 94 109 201 216 O
of 110 112 217 219 O
protocol 113 121 220 228 O
radiation 122 131 229 238 O

Aspartate 0 9 239 248 B-clinical_variable
aminotransferase 10 26 249 265 I-clinical_variable
( 27 28 266 267 I-clinical_variable
AST 28 31 267 270 I-clinical_variable
) 31 32 270 271 I-clinical_variable
and 33 36 272 275 O
alanine 37 44 276 283 B-clinical_variable
aminotransferase 45 61 284 300 I-clinical_variable
( 62 63 301 302 I-clinical_variable
ALT 63 66 302 305 I-clinical_variable
) 66 67 305 306 I-clinical_variable
= 68 69 307 308 O
< 69 70 308 309 O
3 71 72 310 311 B-upper_bound
times 73 78 312 317 I-upper_bound
the 79 82 318 321 I-upper_bound
upper 83 88 322 327 I-upper_bound
limit 89 94 328 333 I-upper_bound
of 95 97 334 336 I-upper_bound
normal 98 104 337 343 I-upper_bound

Eastern 0 7 344 351 B-clinical_variable
Cooperative 8 19 352 363 I-clinical_variable
Oncology 20 28 364 372 I-clinical_variable
Group 29 34 373 378 I-clinical_variable
( 35 36 379 380 I-clinical_variable
ECOG 36 40 380 384 I-clinical_variable
) 40 41 384 385 I-clinical_variable
performance 42 53 386 397 I-clinical_variable
score 54 59 398 403 I-clinical_variable
of 60 62 404 406 O
= 63 64 407 408 O
< 64 65 408 409 O
2 66 67 410 411 B-upper_bound

Histologically 0 14 412 426 O
or 15 17 427 429 O
cytologically 18 31 430 443 O
confirmed 32 41 444 453 O
carcinoma 42 51 454 463 B-cancer
of 52 54 464 466 I-cancer
exocrine 55 63 467 475 I-cancer
pancreatic 64 74 476 486 I-cancer
head 75 79 487 491 I-cancer
amenable 80 88 492 500 O
to 89 91 501 503 O
oncological 92 103 504 515 B-treatment
surgical 104 112 516 524 I-treatment
resection 113 122 525 534 I-treatment
per 123 126 535 538 O
findings 127 135 539 547 O
on 136 138 548 550 O
a 139 140 551 552 O
pancreatic 141 151 553 563 B-treatment
- 151 152 563 564 I-treatment
specific 152 160 564 572 I-treatment
computed 161 169 573 581 I-treatment
tomography 170 180 582 592 I-treatment
( 181 182 593 594 I-treatment
CT 182 184 594 596 I-treatment
) 184 185 596 597 I-treatment
or 186 188 598 600 O
MRI 189 192 601 604 B-treatment
scan 193 197 605 609 I-treatment

History 0 7 610 617 O
of 8 10 618 620 O
prior 11 16 621 626 O
allergic 17 25 627 635 O
reactions 26 35 636 645 O
attributed 36 46 646 656 O
to 47 49 657 659 O
compounds 50 59 660 669 O
of 60 62 670 672 O
CT/ 63 66 673 676 B-allergy_name
MRI 67 70 677 680 B-allergy_name
contrast 71 79 681 689 O
that 80 84 690 694 O
can 85 88 695 698 O
not 88 91 698 701 O
be 92 94 702 704 O
managed 95 102 705 712 O
with 103 107 713 717 O
appropriate 108 119 718 729 O
pre 120 123 730 733 B-treatment
- 123 124 733 734 I-treatment
medication 124 134 734 744 I-treatment
prophylaxis 135 146 745 756 I-treatment
and 147 150 757 760 O
thereby 151 158 761 768 O
preclude 159 167 769 777 O
use 168 171 778 781 O
of 172 174 782 784 O
baseline/ 175 184 785 794 O
follow 185 191 795 801 O
- 191 192 801 802 O
up 192 194 802 804 O
or 195 197 805 807 O
radiation 198 207 808 817 B-treatment
planning 208 216 818 826 I-treatment
imaging 217 224 827 834 I-treatment

History 0 7 835 842 O
of 8 10 843 845 O
prior 11 16 846 851 O
allergic 17 25 852 860 O
reactions 26 35 861 870 O
attributed 36 46 871 881 O
to 47 49 882 884 O
compounds 50 59 885 894 O
of 60 62 895 897 O
similar 63 70 898 905 O
chemical 71 79 906 914 O
or 80 82 915 917 O
biologic 83 91 918 926 O
composition 92 103 927 938 O
as 104 106 939 941 O
capecitabine 107 119 942 954 B-allergy_name

Neoadjuvant 0 11 955 966 B-treatment
chemotherapy 12 24 967 979 I-treatment
will 25 29 980 984 O
be 30 32 985 987 O
permitted 33 42 988 997 O
prior 43 48 998 1003 O
to 49 51 1004 1006 O
the 52 55 1007 1010 O
initiation 56 66 1011 1021 O
of 67 69 1022 1024 O
SBRT 70 74 1025 1029 B-treatment
radiation 75 84 1030 1039 I-treatment
therapy 85 92 1040 1047 I-treatment
on 93 95 1048 1050 O
this 96 100 1051 1055 O
clinical 101 109 1056 1064 O
trial 110 115 1065 1070 O

Patients 0 8 1071 1079 O
with 9 13 1080 1084 O
no 14 16 1085 1087 O
evidence 17 25 1088 1096 O
of 26 28 1097 1099 O
regional 29 37 1100 1108 B-cancer
or 38 40 1109 1111 I-cancer
distant 41 48 1112 1119 I-cancer
metastatic 49 59 1120 1130 I-cancer
disease 60 67 1131 1138 I-cancer
based 68 73 1139 1144 O
on 74 76 1145 1147 O
CT 77 79 1148 1150 O
scan 80 84 1151 1155 O
of 85 87 1156 1158 O
the 88 91 1159 1162 O
chest/ 92 98 1163 1169 O
abdomen 99 106 1170 1177 O
/ 106 107 1177 1178 O
pelvis 107 113 1178 1184 O

Patients 0 8 1185 1193 O
with 9 13 1194 1198 O
primary 14 21 1199 1206 O
ampullary 22 31 1207 1216 B-cancer
, 31 32 1216 1217 O
biliary 33 40 1218 1225 B-cancer
or 41 43 1226 1228 O
duodenal 44 52 1229 1237 B-cancer
cancer 53 59 1238 1244 I-cancer

Patients 0 8 1245 1253 O
with 9 13 1254 1258 O
tumors 14 20 1259 1265 B-cancer
primarily 21 30 1266 1275 O
of 31 33 1276 1278 O
the 34 37 1279 1282 O
body 38 42 1283 1287 O
or 43 45 1288 1290 O
tail 46 50 1291 1295 O
of 51 53 1296 1298 O
the 54 57 1299 1302 O
pancreas 58 66 1303 1311 O
requiring 67 76 1312 1321 O
a 77 78 1322 1323 O
distal 79 85 1324 1330 B-treatment
pancreaticoduodenectomy 86 109 1331 1354 I-treatment

Platelet 0 8 1355 1363 B-clinical_variable
count 9 14 1364 1369 I-clinical_variable
> 15 16 1370 1371 O
= 16 17 1371 1372 O
100,000 18 25 1373 1380 B-lower_bound
cells 26 31 1381 1386 I-lower_bound
/ 31 32 1386 1387 I-lower_bound
mm3 32 35 1387 1390 I-lower_bound

Pregnant 0 8 1391 1399 B-pregnancy

Serum 0 5 1400 1405 B-clinical_variable
creatinine 6 16 1406 1416 I-clinical_variable
within 17 23 1417 1423 O
normal 24 30 1424 1430 O
range 31 36 1431 1436 O
with 37 41 1437 1441 O
a 42 43 1442 1443 O
creatinine 44 54 1444 1454 B-clinical_variable
clearance 55 64 1455 1464 I-clinical_variable
> 65 66 1465 1466 O
= 66 67 1466 1467 O
30 68 70 1468 1470 B-lower_bound
ml 71 73 1471 1473 I-lower_bound
/ 73 74 1473 1474 I-lower_bound
min 74 77 1474 1477 I-lower_bound

Subjects 0 8 1478 1486 O
unable 9 15 1487 1493 O
to 16 18 1494 1496 O
maintain 19 27 1497 1505 O
blood 28 33 1506 1511 B-clinical_variable
glucose 34 41 1512 1519 I-clinical_variable
less 42 46 1520 1524 O
than 47 51 1525 1529 O
200mg 52 57 1530 1535 B-upper_bound
/ 57 58 1535 1536 I-upper_bound
dl 58 60 1536 1538 I-upper_bound

There 0 5 1539 1544 O
must 6 10 1545 1549 O
be 11 13 1550 1552 O
a 14 15 1553 1554 O
minimum 16 23 1555 1562 O
of 24 26 1563 1565 O
2 27 28 1566 1567 B-lower_bound
weeks 29 34 1568 1573 I-lower_bound
between 35 42 1574 1581 O
the 43 46 1582 1585 O
completion 47 57 1586 1596 O
of 58 60 1597 1599 O
any 61 64 1600 1603 O
neoadjuvant 65 76 1604 1615 B-treatment
chemotherapy 77 89 1616 1628 I-treatment
and 90 93 1629 1632 O
the 94 97 1633 1636 O
beginning 98 107 1637 1646 O
of 108 110 1647 1649 O
SBRT 111 115 1650 1654 B-treatment
radiation 116 125 1655 1664 I-treatment
therapy 126 133 1665 1672 I-treatment

Treatment 0 9 1673 1682 B-treatment
with 10 14 1683 1687 I-treatment
a 15 16 1688 1689 I-treatment
non 17 20 1690 1693 I-treatment
- 20 21 1693 1694 I-treatment
approved 21 29 1694 1702 I-treatment
or 30 32 1703 1705 I-treatment
investigational 33 48 1706 1721 I-treatment
drug 49 53 1722 1726 I-treatment
within 54 60 1727 1733 O
28 61 63 1734 1736 B-upper_bound
days 64 68 1737 1741 I-upper_bound
of 69 71 1742 1744 O
study 72 77 1745 1750 B-treatment
treatment 78 87 1751 1760 I-treatment

Tumors 0 6 1761 1767 B-cancer
of 7 9 1768 1770 O
the 10 13 1771 1774 O
body 14 18 1775 1779 O
that 19 23 1780 1784 O
allow 24 29 1785 1790 O
a 30 31 1791 1792 O
surgical 32 40 1793 1801 O
approach 41 49 1802 1810 O
similar 50 57 1811 1818 O
to 58 60 1819 1821 O
pancreatic 61 71 1822 1832 B-cancer
head 72 76 1833 1837 I-cancer
tumors 77 83 1838 1844 I-cancer
are 84 87 1845 1848 O
acceptable 88 98 1849 1859 O

any 0 3 1860 1863 O
invasive 4 12 1864 1872 O
cancer 13 19 1873 1879 B-cancer
in 20 22 1880 1882 O
the 23 26 1883 1886 O
last 27 31 1887 1891 B-upper_bound
5 32 33 1892 1893 I-upper_bound
years 34 39 1894 1899 I-upper_bound

appropriately 0 13 1900 1913 O
treated 14 21 1914 1921 O
ductal 22 28 1922 1928 B-cancer
carcinoma 29 38 1929 1938 I-cancer
in 39 41 1939 1941 I-cancer
situ 42 46 1942 1946 I-cancer

appropriately 0 13 1947 1960 O
treated 14 21 1961 1968 O
in 22 24 1969 1971 O
- 24 25 1971 1972 O
situ 25 29 1972 1976 O
/ 29 30 1976 1977 O
early 30 35 1977 1982 O
stage 36 41 1983 1988 O
cervical 42 50 1989 1997 B-cancer
/ 50 51 1997 1998 O
endometrial 51 62 1998 2009 B-cancer
cancer 63 69 2010 2016 I-cancer

diagnosis 0 9 2017 2026 O
of 10 12 2027 2029 O
low 13 16 2030 2033 O
- 16 17 2033 2034 O
risk 17 21 2034 2038 O
prostate 22 30 2039 2047 B-cancer
cancer 31 37 2048 2054 I-cancer

early 0 5 2055 2060 O
stage 6 11 2061 2066 O
invasive 12 20 2067 2075 B-cancer
carcinoma 21 30 2076 2085 I-cancer
of 31 33 2086 2088 I-cancer
breast 34 40 2089 2095 I-cancer

nursing 0 7 2096 2103 O
women 8 13 2104 2109 B-gender

subjects 0 8 2110 2118 O
with 9 13 2119 2123 O
known 14 19 2124 2129 O
severe 20 26 2130 2136 O
claustrophobia 27 41 2137 2151 B-chronic_disease
or 42 44 2152 2154 O
with 45 49 2155 2159 O
body 50 54 2160 2164 O
habitus 55 62 2165 2172 O
not 63 66 2173 2176 O
compatible 67 77 2177 2187 O
with 78 82 2188 2192 O
the 83 86 2193 2196 O
bore 87 91 2197 2201 O
( 92 93 2202 2203 O
> 93 94 2203 2204 O
300lbs 94 100 2204 2210 B-lower_bound
, 100 101 2210 2211 O
BMI>40 102 108 2212 2218 B-bmi
) 108 109 2218 2219 O

treated 0 7 2220 2227 O
non 8 11 2228 2231 B-cancer
- 11 12 2231 2232 I-cancer
melanoma 12 20 2232 2240 I-cancer
/ 20 21 2240 2241 I-cancer
melanoma 21 29 2241 2249 I-cancer
skin 30 34 2250 2254 I-cancer
cancer 35 41 2255 2261 I-cancer

women 0 5 2262 2267 B-gender
of 6 8 2268 2270 O
child 9 14 2271 2276 O
- 14 15 2276 2277 O
bearing 15 22 2277 2284 O
potential 23 32 2285 2294 O
and 33 36 2295 2298 O
men 37 40 2299 2302 O
must 41 45 2303 2307 O
agree 46 51 2308 2313 B-contraception_consent
to 52 54 2314 2316 I-contraception_consent
use 55 58 2317 2320 I-contraception_consent
adequate 59 67 2321 2329 I-contraception_consent
contraception 68 81 2330 2343 I-contraception_consent
( 82 83 2344 2345 I-contraception_consent
hormonal 83 91 2345 2353 I-contraception_consent
or 92 94 2354 2356 I-contraception_consent
barrier 95 102 2357 2364 I-contraception_consent
method 103 109 2365 2371 I-contraception_consent
of 110 112 2372 2374 I-contraception_consent
birth 113 118 2375 2380 I-contraception_consent
control 119 126 2381 2388 I-contraception_consent
; 126 127 2388 2389 I-contraception_consent
abstinence 128 138 2390 2400 I-contraception_consent
) 138 139 2400 2401 I-contraception_consent
from 140 144 2402 2406 O
the 145 148 2407 2410 O
point 149 154 2411 2416 O
of 155 157 2417 2419 O
study 158 163 2420 2425 O
entry 164 169 2426 2431 O
and 170 173 2432 2435 O
for 174 177 2436 2439 O
the 178 181 2440 2443 O
duration 182 190 2444 2452 O
of 191 193 2453 2455 O
all 194 197 2456 2459 O
active 198 204 2460 2466 O
treatments 205 215 2467 2477 O

